Synthesis, characterization, and in vitro and in silico antibacterial evaluation of 5-(3-nitrophenyl)-1,3,4-thiadiazol-2-amine
Abstract
Introduction: This study reports the synthesis, structural characterization, and antibacterial evaluation of 5-(3-nitrophenyl)-1,3,4-thiadiazol-2-amine (NPTA), a commercially available thiadiazole derivative with potential antimicrobial activity. Methods: NPTA was synthesized through a green, one-pot condensation reaction between thiosemicarbazide and 3-nitrobenzoic acid in absolute ethanol, affording a pale-yellow crystalline solid with a melting point of 110 °C-112 °C. The compound was characterized using Fourier-transform infrared (FTIR) and nuclear magnetic resonance (NMR) spectroscopy, confirming its structure. In vitro antibacterial assays, in silico ADMET and toxicity profiling, molecular docking, frontier molecular orbital (FMO) analysis, and 200 ns molecular dynamics simulations were performed. Results: In vitro antibacterial assays revealed significant activity against Klebsiella pneumoniae ATCC 13883, Acinetobacter baumannii, and Listeria monocytogenes ATCC 19114, with growth inhibition zones of 25.63 ± 0.17 mm, 29.09 ± 1.31 mm, and 26.65 ± 0.19 mm, respectively, and minimum inhibitory concentrations (MICs) ranging from 50 to 100 µg/mL. In silico ADMET and toxicity profiling predicted favourable drug-likeness, absorption, and safety. Molecular docking indicated strong binding affinities (-6.2 to -7.0 kcal/mol) with key bacterial targets, i.e., DNA gyrase subunit B (PDB: 1KZN) and penicillin-binding protein 4 (PDB: 3HUN). Frontier molecular orbital (FMO) analysis revealed a HOMO-LUMO energy gap of 3.79 eV, suggesting high electronic stability and reactivity. Furthermore, 200 ns molecular dynamics simulations confirmed the temporal stability of NPTA-protein complexes, particularly with DNA gyrase subunit B. Discussion: These results demonstrate the promising antibacterial potential of NPTA and support its further development as a multifunctional thiadiazole-based antimicrobial candidate.
Related
- Synthesis, RSM-based optimization, biological evaluation, and molecular modeling of novel (R)-carvone-derived isoxazole derivatives as antibacterial agents
- Synthesis, Characterization, and Antibacterial Efficacy of Cu-ZIF-8: In Vitro Study of Multidrug-Resistant Gram-Positive and Gram-Negative Bacteria
- Eco-friendly synthesis and multifunctional characterization of ZrO₂/Cu₄O₃/MnO₂/CuMnO₂ nanocomposite with enhanced thermal stability and antibacterial activity.
- Hydrothermal Synthesis of Water-Dispersible Fluorescent Carbon Dots from Renewable Plant Precursors: Antibacterial Activity and Comparative Characterization
- Silver-Bacterial Cellulose-Areca catechu Extract Nanocomposite Biofilm for Sustainable Food Packaging: Synthesis, Characterization, and Antibacterial Activity.
BibTeX
@article{sehmi2026synthesis,
title = {{Synthesis, characterization, and in vitro and in silico antibacterial evaluation of 5-(3-nitrophenyl)-1,3,4-thiadiazol-2-amine}},
author = {Abdelghani Sehmi and Farouk Boudou and Ahcene Keziz and Amal Belakredar and Huda Alsaeedi and Mikhael Bechelany and Gemma K Kinsella and Ahmed Barhoum},
journal = {Frontiers in Chemistry},
year = {2026},
month = jul,
doi = {10.3389/fchem.2026.1848149},
url = {https://hal.umontpellier.fr/hal-05770476v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Synthesis, characterization, and in vitro and in silico antibacterial evaluation of 5-(3-nitrophenyl)-1,3,4-thiadiazol-2-amine
AU - Abdelghani Sehmi
AU - Farouk Boudou
AU - Ahcene Keziz
AU - Amal Belakredar
AU - Huda Alsaeedi
AU - Mikhael Bechelany
AU - Gemma K Kinsella
AU - Ahmed Barhoum
PY - 2026
DA - 2026/07/08
JO - Frontiers in Chemistry
DO - 10.3389/fchem.2026.1848149
UR - https://hal.umontpellier.fr/hal-05770476v1
AB - Introduction: This study reports the synthesis, structural characterization, and antibacterial evaluation of 5-(3-nitrophenyl)-1,3,4-thiadiazol-2-amine (NPTA), a commercially available thiadiazole derivative with potential antimicrobial activity. Methods: NPTA was synthesized through a green, one-pot condensation reaction between thiosemicarbazide and 3-nitrobenzoic acid in absolute ethanol, affording a pale-yellow crystalline solid with a melting point of 110 °C-112 °C. The compound was characterized using Fourier-transform infrared (FTIR) and nuclear magnetic resonance (NMR) spectroscopy, confirming its structure. In vitro antibacterial assays, in silico ADMET and toxicity profiling, molecular docking, frontier molecular orbital (FMO) analysis, and 200 ns molecular dynamics simulations were performed. Results: In vitro antibacterial assays revealed significant activity against Klebsiella pneumoniae ATCC 13883, Acinetobacter baumannii, and Listeria monocytogenes ATCC 19114, with growth inhibition zones of 25.63 ± 0.17 mm, 29.09 ± 1.31 mm, and 26.65 ± 0.19 mm, respectively, and minimum inhibitory concentrations (MICs) ranging from 50 to 100 µg/mL. In silico ADMET and toxicity profiling predicted favourable drug-likeness, absorption, and safety. Molecular docking indicated strong binding affinities (-6.2 to -7.0 kcal/mol) with key bacterial targets, i.e., DNA gyrase subunit B (PDB: 1KZN) and penicillin-binding protein 4 (PDB: 3HUN). Frontier molecular orbital (FMO) analysis revealed a HOMO-LUMO energy gap of 3.79 eV, suggesting high electronic stability and reactivity. Furthermore, 200 ns molecular dynamics simulations confirmed the temporal stability of NPTA-protein complexes, particularly with DNA gyrase subunit B. Discussion: These results demonstrate the promising antibacterial potential of NPTA and support its further development as a multifunctional thiadiazole-based antimicrobial candidate.
SN - 2296-2646
ER -